NU553 Unit 4 Exam Preparation

Student Name

Purdue University Globle 

NU553 Advanced Pharmacology and Pharmacotherapeutics

Prof. Name

Date

NU553 Unit 4 Exam Preparation: Complete Study Guide for Advanced Pharmacology Success

Preparing for the NU553 Unit 4 Exam requires a strong understanding of common neurological, psychiatric, endocrine, and gastrointestinal disorders, along with evidence-based pharmacologic management. The exam primarily tests your ability to recognize clinical presentations, select appropriate first-line therapies, understand medication mechanisms of action, identify contraindications and adverse effects, and apply treatment guidelines to patient scenarios. Focusing on the major disease states outlined below will help strengthen your clinical decision-making and improve exam readiness.

Headaches

Headaches are among the most common neurological disorders encountered in clinical practice. Students should understand how to differentiate headache types based on clinical presentation, identify underlying causes, and select appropriate acute and preventive treatments.

Types of Headaches

Common headache classifications include:

• Migraine

• Tension-type headache

• Cluster headache

• Medication-overuse headache (MOH)

Each type presents with distinct symptoms, triggers, and treatment approaches.

First-Line Pharmacologic Treatment

For every headache type, understand:

• Mechanism of action

• Primary indications

• Common adverse effects

• Contraindications

• Major drug interactions

Preventive therapy is generally recommended for patients experiencing frequent or disabling migraines. Common prophylactic medication classes include:

• Beta-blockers

• Antiepileptic medications

• Calcitonin gene-related peptide (CGRP) inhibitors

• Certain antidepressants

Medication-overuse headache should always be considered in patients frequently using abortive medications such as triptans or NSAIDs.

Seizure Disorders

Effective seizure management requires accurate seizure classification and appropriate antiepileptic drug selection.

Types of Seizures

Students should distinguish between:

• Focal seizures

• Generalized seizures

• Absence seizures

• Tonic-clonic seizures

• Myoclonic seizures

Pharmacologic Management

Focus on understanding:

• First-line medications for each seizure type

• Mechanisms of action

• Boxed warnings

• Serious adverse effects

• Contraindications

• Significant drug interactions

Dose titration is particularly important. Most antiseizure medications require gradual dose escalation to reduce toxicity while optimizing therapeutic response. Monotherapy is preferred before combining multiple agents.

NU553 Unit 4 Exam Preparation

Alzheimer’s Disease

Alzheimer’s disease is a progressive neurodegenerative disorder characterized by declining cognitive function and memory impairment.

First-Line Treatment

Cholinesterase inhibitors remain first-line therapy during mild to moderate disease.

Understand:

• Mechanism of action

• Common gastrointestinal side effects

• Contraindications

• Appropriate patient selection

Memantine

Memantine is typically introduced during moderate to severe disease.

Review:

• Mechanism of action

• Clinical indications

• Adverse effects

• Combination therapy considerations

Behavioral symptoms may require selective serotonin reuptake inhibitors (SSRIs) or carefully selected antipsychotics when clinically appropriate.

Caregiver education and patient safety should remain central components of management.

Parkinson’s Disease

Parkinson’s disease results from progressive dopamine depletion within the basal ganglia.

Clinical Features

Students should recognize:

• Resting tremor

• Bradykinesia

• Rigidity

• Postural instability

• Nonmotor symptoms

Medication Therapy

Understand when treatment should begin and review:

• Carbidopa/levodopa

• Dopamine agonists

• MAO-B inhibitors

• COMT inhibitors

• Amantadine

Study:

• Mechanisms of action

• Relative potency

• Dose titration

• Wearing-off phenomenon

• Major adverse effects

• Drug interactions

Advanced therapies should also be reviewed for patients with refractory symptoms.

Patient counseling should emphasize fall prevention, medication adherence, and recognition of motor fluctuations.

Major Depressive Disorder

Major depressive disorder (MDD) is diagnosed using established diagnostic criteria that evaluate symptom duration and functional impairment.

First-Line Pharmacotherapy

Primary treatment includes:

• Selective serotonin reuptake inhibitors (SSRIs)

• Serotonin-norepinephrine reuptake inhibitors (SNRIs)

Students should understand:

• Mechanism of action

• Expected response timeline

• Treatment duration

• Common adverse effects

• Contraindications

Alternative Therapies

Review additional medication classes, including:

• Bupropion

• Mirtazapine

• Tricyclic antidepressants

• Monoamine oxidase inhibitors (MAOIs)

Bipolar Disorder

Differentiating Bipolar I from Bipolar II is essential for selecting appropriate pharmacotherapy.

Key Areas to Review

Study:

• Diagnostic differences

• Mood stabilizers

• Atypical antipsychotics

• Treatment goals

• Monitoring requirements

• Risk of antidepressant-induced mania

Understand medication mechanisms, side effects, contraindications, and appropriate duration of therapy.

Anxiety Disorders

Anxiety disorders include multiple clinical conditions with overlapping symptoms but different treatment strategies.

Common Anxiety Disorders

Review:

• Generalized anxiety disorder

• Panic disorder

• Social anxiety disorder

• Obsessive-compulsive disorder

• Post-traumatic stress disorder

Pharmacologic Management

First-line treatment typically includes SSRIs and SNRIs.

Students should know:

• Mechanisms of action

• Time to clinical response

• Duration of treatment

• Adverse effects

• Contraindications

Responsible benzodiazepine prescribing is an important exam topic, including:

• Appropriate indications

• Dependency risks

• Contraindications

• Safe tapering strategies

Second-line pharmacologic options should also be reviewed.

Sleep Disorders

Sleep disorders require identifying the specific sleep disturbance before selecting therapy.

Insomnia

Determine whether the patient has:

• Difficulty falling asleep

• Difficulty staying asleep

• Early awakening

• Nonrestorative sleep

Medication selection depends on the specific sleep complaint.

Review:

• Benzodiazepine receptor agonists

• Orexin receptor antagonists

• Melatonin receptor agonists

• Sedating antidepressants

Restless Legs Syndrome

Review first-line medications, mechanisms of action, contraindications, and adverse effects.

Narcolepsy

Study:

• Wake-promoting agents

• Stimulants

• Sodium oxybate

Attention-Deficit/Hyperactivity Disorder (ADHD)

Treatment focuses on stimulant and non-stimulant medications.

Students should understand:

• Mechanism of action

• Adverse effects

• Contraindications

• Cardiovascular precautions

• Significant drug interactions

Substance Use Disorders

Evidence-based pharmacologic therapy is essential for substance use disorder management.

Alcohol Use Disorder

Review first-line medications, including:

• Naltrexone

• Acamprosate

• Disulfiram

Understand mechanisms, contraindications, and adverse effects.

Opioid Use Disorder

Study:

• Buprenorphine

• Methadone

• Naltrexone

Focus on indications, safety considerations, and monitoring requirements.

Nausea, Vomiting, Constipation, and Diarrhea

Proper treatment depends on identifying the underlying cause.

Nausea and Vomiting

Recognize therapy selection for:

• Motion sickness

• Pregnancy-related nausea

• Chemotherapy-induced nausea

• Postoperative nausea

Study first-line and second-line medications, mechanisms, contraindications, and important red flags requiring urgent evaluation.

Constipation

Management begins with lifestyle modifications, including adequate hydration, increased dietary fiber, and regular physical activity.

Students should review treatment options for:

• Chronic idiopathic constipation

• Opioid-induced constipation

Understand first-, second-, and third-line pharmacologic therapies.

Diarrhea

Treatment requires determining the underlying cause while preventing dehydration.

Review:

• Oral rehydration therapy

• Antidiarrheal medications

• Contraindications for antimotility agents

Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD)

Effective management combines lifestyle interventions with pharmacologic therapy.

Lifestyle Modifications

Recommended interventions include:

• Weight reduction

• Smoking cessation

• Avoiding late-night meals

• Elevating the head of the bed

• Limiting dietary triggers

Medication Therapy

Review:

• Proton pump inhibitors

• H2 receptor antagonists

• Antacids

• Sucralfate

Students should understand mechanisms, adverse effects, contraindications, and major drug interactions.

Helicobacter pylori Treatment

Study guideline-based eradication regimens and indications for combination antibiotic therapy.

Liver Disease

Management focuses on preventing complications associated with chronic liver disease.

Variceal Hemorrhage

Review:

• Primary prophylaxis

• Acute treatment

• Medication mechanisms

• Contraindications

Ascites

Understand first-line diuretic therapy, monitoring parameters, and adverse effects.

Hepatic Encephalopathy

Students should review:

• Lactulose

• Rifaximin

Focus on mechanisms of action, adverse effects, and treatment goals.

Additional Topics

Also review:

• Community-acquired spontaneous bacterial peritonitis

• Chronic hepatitis B treatment during pregnancy

Diabetes Mellitus

Diabetes management combines lifestyle interventions with individualized pharmacotherapy.

Lifestyle Management

Core recommendations include:

• Medical nutrition therapy

• Weight management

• Physical activity

• Smoking cessation

Important Concepts

Students should differentiate:

• Somogyi effect

• Dawn phenomenon

Antidiabetic Medications

Review major medication classes, including:

• Metformin

• GLP-1 receptor agonists

• SGLT2 inhibitors

• DPP-4 inhibitors

• Sulfonylureas

• Thiazolidinediones

• Alpha-glucosidase inhibitors

• Bile acid sequestrants

• Insulin

• Inhaled insulin (Afrezza)

For each medication class, understand:

• Mechanism of action

• Major adverse effects

• Contraindications

• Drug interactions

• Cardiovascular and renal benefits where applicable

Insulin Therapy

Know recommended starting doses, titration strategies, and hypoglycemia prevention.

Thyroid and Parathyroid Disorders

Understanding endocrine laboratory interpretation is essential for diagnosis and treatment.

Hypothyroidism

Review:

• Diagnostic laboratory findings

• Levothyroxine dosing

• Administration recommendations

• Monitoring schedule

• Drug interactions

• Pregnancy considerations

Hyperthyroidism

Study:

• Diagnostic laboratory patterns

• Methimazole versus propylthiouracil

• Adverse effects

• Symptom control with beta-blockers

• Radioactive iodine counseling

• Thyroid storm management

Parathyroid Disorders

Understand treatment approaches for:

• Hyperparathyroidism

• Hypoparathyroidism

Practice Questions With Correct Answers

Question 1

A patient experiences 6–8 migraines each month despite appropriate abortive therapy. Which medication is the preferred first-line preventive treatment?

Answer: B. Propranolol

Propranolol is an evidence-supported first-line medication for migraine prevention and significantly reduces attack frequency.

Question 2

Why must lamotrigine be titrated slowly?

Answer: D. Rapid titration increases the risk of Stevens-Johnson syndrome.

Gradual dose escalation minimizes the risk of severe life-threatening skin reactions.

Question 3

A patient taking donepezil develops nausea and vomiting. What counseling should be provided?

Answer: D. These side effects are common and often improve over time.

Most gastrointestinal adverse effects lessen as therapy continues.

Question 4

Parkinson’s symptoms return before the next scheduled levodopa dose. What is this phenomenon called?

Answer: C. Wearing-off effect

The wearing-off effect occurs as levodopa concentrations decline before the next scheduled dose.

Question 5

Which medication is preferred for bipolar II depression while minimizing the risk of mania?

Answer: C. Lamotrigine

Lamotrigine effectively treats bipolar depression and carries a relatively low risk of mood switching.

Question 6

Which antiemetic blocks dopamine receptors and may cause extrapyramidal symptoms?

Answer: B. Prochlorperazine

Dopamine receptor blockade increases the risk of extrapyramidal adverse effects.

Question 7

Which medication provides cardiovascular protection and weight loss in patients with type 2 diabetes?

Answer: A. Semaglutide

Semaglutide improves glycemic control while reducing cardiovascular risk and promoting weight loss.

Question 8

What is the ADA-recommended starting dose for basal insulin?

Answer: A. 10 units daily or 0.1–0.2 units/kg/day

The dose should be individualized and titrated based on fasting blood glucose.

Question 9

What is the most important counseling point for levothyroxine?

Answer: B. Take on an empty stomach and separate from calcium and iron supplements.

Food and mineral supplements significantly reduce levothyroxine absorption.

Question 10

A patient taking methimazole develops fever and sore throat. What is the appropriate action?

Answer: B. Stop methimazole and seek immediate evaluation.

These symptoms may indicate agranulocytosis, a rare but life-threatening adverse effect requiring urgent assessment.

Key Exam Takeaways

• Migraine prevention commonly begins with beta-blockers or other evidence-based prophylactic therapies.

• Lamotrigine requires slow titration because of the risk of Stevens-Johnson syndrome.

• Donepezil commonly causes temporary gastrointestinal side effects.

• Wearing-off is a common motor complication of long-term levodopa therapy.

• SSRIs and SNRIs remain first-line pharmacotherapy for most anxiety disorders and major depressive disorder.

• GLP-1 receptor agonists provide cardiovascular benefits and promote weight loss in many patients with type 2 diabetes.

• Levothyroxine absorption is significantly reduced by food, calcium, and iron supplements.

• Fever and sore throat during methimazole therapy require immediate evaluation for possible agranulocytosis.

Frequently Asked Questions

What topics are most important for the NU553 Unit 4 exam?

High-yield topics include headache disorders, seizures, Alzheimer’s disease, Parkinson’s disease, depression, bipolar disorder, anxiety disorders, diabetes, thyroid disorders, gastrointestinal pharmacology, liver disease, sleep disorders, ADHD, and substance use disorders. Students should focus on medication mechanisms, first-line treatments, contraindications, adverse effects, and patient counseling.

Which medication classes appear most frequently on pharmacology exams?

Frequently tested classes include SSRIs, SNRIs, beta-blockers, antiepileptics, GLP-1 receptor agonists, SGLT2 inhibitors, insulin, proton pump inhibitors, cholinesterase inhibitors, levodopa combinations, thyroid medications, and antithyroid drugs.

Why is understanding medication mechanisms important?

Knowing the mechanism of action helps explain therapeutic effects, predict adverse reactions, recognize drug interactions, and choose appropriate treatments in clinical scenarios.

What is the best strategy for preparing for NU553 pharmacology exams?

Combine lecture notes, clinical guidelines, medication comparison charts, practice questions, and case-based learning. Pay special attention to first-line therapies, boxed warnings, contraindications, and patient education points.

Effective NU553 Unit 4 preparation centers on mastering disease recognition, evidence-based pharmacologic treatment, medication safety, and patient counseling. Strong knowledge of clinical guidelines, medication mechanisms, contraindications, and therapeutic monitoring will improve both examination performance and future clinical practice.

References

American Diabetes Association Professional Practice Committee. (2025). Standards of care in diabetes—2025. Diabetes Care, 48(Suppl. 1). https://doi.org/10.2337/dc25-SINT

American Psychiatric Association. (2023). The American Psychiatric Association practice guideline for the treatment of patients with major depressive disorder. https://psychiatryonline.org

American Academy of Neurology. (2021). Practice guideline recommendations for migraine prevention and treatment. https://www.aan.com

Katzung, B. G., & Trevor, A. J. (2024). Basic & Clinical Pharmacology (16th ed.). McGraw-Hill. https://accessmedicine.mhmedical.com

Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2023). Goodman & Gilman’s: The pharmacological basis of therapeutics (14th ed.). McGraw-Hill. https://accessmedicine.mhmedical.com

NU553 Unit 4 Exam Preparation

Joint Formulary Committee. (2025). British National Formulary (BNF). https://bnf.nice.org.uk

National Institute for Health and Care Excellence. (2025). NICE guidelines. https://www.nice.org.uk/guidance